Could a common cholesterol pill fight cervical cancer? new trial investigates

NCT ID NCT06191133

Recruiting now Disease control Sponsor: Lindsay Ferguson, MD Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study is testing whether fenofibrate, a drug normally used to lower cholesterol, can help treat HPV-related cervical cancer and high-grade cervical dysplasia. Researchers will give the drug to 24 adults before their planned surgery and then examine tissue samples to see if it restores normal p53 function and changes tumor metabolism. The goal is to understand if fenofibrate can slow or stop tumor growth, not to cure the disease at this stage.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer cervical carcinoma cervical intraepithelial neoplasia cervical intraepithelial neoplasia grade 2/3 dysplasia of cervix

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL INTRAEPITHELIAL NEOPLASIA INVASIVE CERVICAL CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
RECRUITING

Cleveland, Ohio, 44106, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••